Finance

Lists
BLS:ASX
BLS Pharmaceuticals Ltd
A$1.18
0.00%
(0.00) 1D
Sep 11, 4:10:14 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BLS...
Open
A$1.18
High
A$1.20
Low
A$1.11
Mkt. cap
271.87M
Avg. vol.
310.74K
Volume
606.73K
P/E ratio
17.61
52-wk high
A$1.21
52-wk low
A$0.76
EPS
A$0.07
Shares outstanding
230.40M
No. of employees
16
Open
A$1.18
High
A$1.20
Low
A$1.11
Mkt. cap
271.87M
Avg. vol.
310.74K
Volume
606.73K
P/E ratio
17.61
52-wk high
A$1.21
52-wk low
A$0.76
EPS
A$0.07
Shares outstanding
230.40M
No. of employees
16
About BLS Pharmaceuticals Ltd
CEO-
Employees16
Founded1998
Headquarters-
SectorHealth care
Websiteblspharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.58M
15.58M
21.38M
21.38M
Cost of goods sold
6.86M
6.86M
10.36M
10.36M
Cost of revenue
6.86M
6.86M
10.36M
10.36M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.16M
3.16M
5.00M
5.00M
Operating expense
3.78M
3.78M
6.19M
6.19M
Total operating expenses
10.63M
10.63M
16.55M
16.55M
Operating income
4.94M
4.94M
4.83M
4.83M
Other non operating income
-1.09M
-1.09M
-905.22K
-905.22K
EBT including unusual items
3.67M
3.67M
3.91M
3.91M
EBT excluding unusual items
3.80M
3.80M
3.78M
3.78M
Income tax expense
-
-
-119.76K
-119.76K
Effective tax rate
-
-
-3.06%
-3.06%
Other operating expenses
-
-
-
-
Net income
3.67M
3.67M
4.03M
4.03M
Net profit margin
23.57%
23.57%
18.84%
18.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
34.08K
34.08K
Interest expense
-48.48K
-48.48K
-181.52K
-181.52K
Net interest expenses
-48.48K
-48.48K
-147.44K
-147.44K
Depreciation and amortization charges
311.69K
311.69K
381.59K
381.59K
EBITDA
5.12M
5.12M
4.94M
4.94M
Gain or loss from assets sale
-
-
11.52K
11.52K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps